-
EP1543850
European procedure
Extract from the Register of European Patents
EP About this file: EP1543850
| EP1543850 - Activatable bioactive implantable vascular occlusion device [Right-click to bookmark this link] | |||
| Former [2005/25] | Activatable bioactive implantable medical device | ||
| [2012/03] | Status | No opposition filed within time limit Status updated on 17.05.2013 Database last updated on 09.05.2025 | Most recent event Tooltip | 17.05.2013 | No opposition filed within time limit | published on 19.06.2013 [2013/25] | Applicant(s) | For all designated states Codman & Shurtleff, Inc. 325 Paramount Drive Raynham, MA 02767 / US | [2012/38] |
| Former [2012/28] | For all designated states Cordis Neurovascular, Inc. 14000 N.W. 57th Court Miami Lakes Florida 33014 / US | ||
| Former [2005/25] | For all designated states Cordis Neurovascular, Inc. 14000 N.W. 57th Court Miami Lakes, Florida 33014 / US | Inventor(s) | 01 /
Jones, Donald K. 4945 N.W. 82nd Terrace Lauderhill Florida 33351 / US | 02 /
Lorenzo, Juan A. 3650 S.W. 106 Terrace Davie Florida 33328 / US | 03 /
Pomeranz, Mark L. 11980 Piccadilly Place Davie Florida 33325 / US | 04 /
Sherman, Darren 1216 S.E. 5th Court, Ft. Lauderdale Florida 33301 / US | [2005/25] | Representative(s) | Tunstall, Christopher Stephen, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2012/28] | Tunstall, Christopher Stephen, et al Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | ||
| Former [2005/25] | Tunstall, Christopher Stephen, et al Carpmaels & Ransford, 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 04257861.7 | 16.12.2004 | [2005/25] | Priority number, date | US20030738477 | 17.12.2003 Original published format: US 738477 | US20040868152 | 15.06.2004 Original published format: US 868152 | [2005/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1543850 | Date: | 22.06.2005 | Language: | EN | [2005/25] | Type: | B1 Patent specification | No.: | EP1543850 | Date: | 11.07.2012 | Language: | EN | [2012/28] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.04.2005 | Classification | IPC: | A61L31/10, A61L31/16, A61B17/12 | [2005/25] | CPC: |
A61L31/16 (EP);
A61B17/12022 (EP);
A61B17/12113 (EP);
A61B17/1215 (EP);
A61B17/1219 (EP);
A61L31/10 (EP);
A61B2017/00831 (EP);
A61B2017/00893 (EP);
A61B2017/00898 (EP);
| Designated contracting states | DE, FR, GB, NL [2006/11] |
| Former [2005/25] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Aktivierbare bioaktive implantierbare Gefässokklusionsvorrichtung | [2012/03] | English: | Activatable bioactive implantable vascular occlusion device | [2012/03] | French: | Dispositif d'occlusion vasculaire bioactif et implantable pouvant être activé | [2012/03] |
| Former [2005/25] | Aktivierbare bioaktive implantierbare medizinische Vorrichtung | ||
| Former [2005/25] | Activatable bioactive implantable medical device | ||
| Former [2005/25] | Dispositif médical bioactif et implantable pouvant être activé | Examination procedure | 01.12.2005 | Examination requested [2006/05] | 25.02.2008 | Despatch of a communication from the examining division (Time limit: M06) | 24.07.2008 | Reply to a communication from the examining division | 25.08.2009 | Despatch of a communication from the examining division (Time limit: M06) | 04.03.2010 | Reply to a communication from the examining division | 05.01.2012 | Communication of intention to grant the patent | 04.05.2012 | Fee for grant paid | 04.05.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.02.2008 | Opposition(s) | 12.04.2013 | No opposition filed within time limit [2013/25] | Fees paid | Renewal fee | 13.12.2006 | Renewal fee patent year 03 | 12.12.2007 | Renewal fee patent year 04 | 31.03.2008 | Renewal fee patent year 05 | 11.12.2009 | Renewal fee patent year 06 | 15.12.2010 | Renewal fee patent year 07 | 12.12.2011 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO0040278 (ANGIOTECH PHARM INC [CA], et al) [X] 1,2,4,7-10 * page 14, line 3 - page 17, line 23 * * page 21, line 6 - line 12 * * claim - * [Y] 1-10; | [DY]US6299619 (GREENE JR GEORGE R [US], et al) [DY] 1-10 * column 3, line 62 - column 4, line 37 * * column 6, line 66 - column 7, line 11 * * claim - *; | [Y]US2002123801 (PACETTI STEPHEN D [US], et al) [Y] 1-10 * paragraph [0002] * * paragraph [0042] * * paragraph [0057] * * paragraphs [0061] - [0063] * * paragraph [0095] * * paragraph [0122] ** paragraph [0128] *; | [X]WO03064383 (ARIAD GENE THERAPEUTICS INC [US], et al) [X] 1,5,7-10 * page 57, line 7 - line 29 * * page 62, line 15 - line 42 * * page 67, line 34 - line 44 *; | [Y]US2003171770 (KUSLEIKA RICHARD S [US], et al) [Y] 1-10 * paragraph [0051] *; | [X]WO03092791 (SCIMED LIFE SYSTEMS INC [US]) [X] 1,4,5,7-10 * page 1, line 10 - line 17 * * page 4, line 6 - line 21 * * page 8, line 24 - line 33 * * page 15, line 33 - line 34 * * claim - * |